You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,568,855


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,568,855 protect, and when does it expire?

Patent 10,568,855 protects PHEXXI and is included in one NDA.

This patent has twenty-four patent family members in fifteen countries.

Summary for Patent: 10,568,855
Title:Compositions and methods for enhancing the efficacy of contraceptive microbicides
Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
Inventor(s): Guthrie; Wendell (San Diego, CA)
Assignee: Evofem, Inc. (San Diego, CA)
Application Number:16/239,314
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 10,568,855: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 10,568,855, titled "Compositions and methods for enhancing the efficacy of contraceptive microbicides," is a significant patent in the field of medical and veterinary science, particularly in the area of contraceptive technologies. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes compositions and methods designed to enhance the efficacy of contraceptive microbicides. Specifically, it involves a negatively charged, non-absorbable, high molecular weight polymer gel that maintains vaginal pH below 5 in the presence of semen, thereby enhancing the effectiveness of contraceptive microbicides[4].

Key Components

  • The composition includes lactic acid, citric acid, and potassium bitartrate, which are crucial for maintaining the desired pH level.
  • The polymer gel is designed to be non-absorbable and high in molecular weight, ensuring it remains effective in the vaginal environment.

Scope of the Patent

Claims

The patent includes several claims that define the scope of the invention:

  • Composition Claims: These claims specify the ingredients and their proportions, such as the use of lactic acid, citric acid, and potassium bitartrate.
  • Method Claims: These claims outline the methods for preparing and using the composition to enhance contraceptive efficacy.
  • Use Claims: These claims detail the specific uses of the composition, including its application as a vaginal gel to maintain pH levels and enhance microbicide efficacy[4].

Classification

The patent is classified under various categories within the International Patent Classification (IPC) system:

  • A61K31/185: Medicinal preparations containing organic active ingredients, specifically acids and their salts.
  • A61K31/19: Carboxylic acids.
  • A61P15/00: Drugs for genital or sexual disorders; contraceptives[4].

Patent Landscape Analysis

Competitor Identification

Patent landscape analysis helps identify key competitors in the field of contraceptive technologies. Companies like Evofem Biosciences, Inc., which is associated with this patent, are significant players. Other companies involved in similar technologies include those mentioned in related patent disputes, such as Padagis Israel Pharmaceuticals Ltd.[5].

Market Developments

The patent landscape reveals several market developments:

  • Litigation and Settlements: The patent has been involved in litigation, with cases such as Evofem Biosciences, Inc. v. Padagis Israel Pharmaceuticals Ltd., where Padagis amended its certifications and the claims were dismissed without prejudice[5].
  • Licensing and Collaborations: The patent's scope and claims can influence licensing strategies and collaborations within the industry. For instance, identifying patents that are about to expire or have not been updated can guide licensing decisions[3].

Technological Trends

The patent landscape analysis also highlights technological trends:

  • Contraceptive Microbicides: There is a growing interest in enhancing the efficacy of contraceptive microbicides, with several patents focusing on maintaining vaginal pH and using polymer gels.
  • Material Science: The use of high molecular weight polymer gels and specific acids indicates a focus on material science in developing these compositions[4].

Legal Status and Expiry Dates

Current Status

The patent is currently active, with no indication of it being revoked or expired. However, the legal status can change based on ongoing litigation and patent office actions[4].

Expected Expiry Dates

Understanding the expected expiry dates of patents is crucial for strategic planning. The expiry date of this patent would be 20 years from the filing date, assuming no extensions or adjustments[3].

Strategic Implications

Research and Development

The insights from this patent can guide R&D efforts in developing new contraceptive technologies. Identifying the strengths and weaknesses of existing patents helps in creating innovative solutions and improving current products[3].

Business Strategies

  • Licensing: Knowing which patents are about to expire or have not been updated can help in formulating licensing strategies.
  • Competitor Analysis: Understanding the patent landscape helps in identifying key competitors and their technological focus areas.
  • Market Opportunities: The analysis can reveal market opportunities, such as areas with less competition or emerging trends in contraceptive technologies[3].

Key Takeaways

  • Composition and Method: The patent involves a specific composition and method for enhancing contraceptive microbicide efficacy using a polymer gel.
  • Claims and Classification: The patent includes detailed claims and is classified under specific IPC categories related to medicinal preparations and contraceptives.
  • Patent Landscape: The analysis helps in identifying competitors, market trends, and strategic opportunities in the field of contraceptive technologies.
  • Legal and Expiry Status: Understanding the current legal status and expected expiry dates is crucial for strategic planning.

FAQs

Q: What is the primary purpose of the composition described in US Patent 10,568,855?

A: The primary purpose is to enhance the efficacy of contraceptive microbicides by maintaining vaginal pH below 5 in the presence of semen.

Q: Which companies are involved in the litigation related to this patent?

A: Companies such as Evofem Biosciences, Inc. and Padagis Israel Pharmaceuticals Ltd. are involved in litigation related to this patent.

Q: How does the patent landscape analysis benefit businesses in this field?

A: It helps in identifying competitors, understanding market trends, and formulating licensing and R&D strategies.

Q: What are the key components of the composition described in the patent?

A: The key components include lactic acid, citric acid, and potassium bitartrate, along with a high molecular weight polymer gel.

Q: What is the expected expiry date of this patent?

A: The expected expiry date is 20 years from the filing date, assuming no extensions or adjustments.

Sources

  1. US Patent and Trademark Office - Patent Claims Research Dataset Documentation.
  2. Google Patents - US10568855B2 - Compositions and methods for enhancing the efficacy of contraceptive microbicides.
  3. Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis.
  4. Robins Kaplan - ANDA Litigation Settlements of Q3 - Fall 2023 | Hatch-Waxman.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,568,855

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Evofem Inc PHEXXI citric acid; lactic acid; potassium bitartrate GEL;VAGINAL 208352-001 May 22, 2020 RX Yes Yes 10,568,855 ⤷  Subscribe PREVENTION OF PREGNANCY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,568,855

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013274815 ⤷  Subscribe
Australia 2017206199 ⤷  Subscribe
Brazil 112014030984 ⤷  Subscribe
China 104487054 ⤷  Subscribe
China 110693812 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.